Vaccines are an especially risky proposition for pharmaceutical manufacturers since the costs are higher than for other types of drugs and demand could drop drastically once a crisis is over.
By
“Building Sustainable Healthcare Systems through Innovation and Entrepreneurship” will bring together entrepreneurs, academics, healthcare professionals and policymakers from around the world.
By
MIT study explores the key factors behind patient outcomes in clinical trials evaluating new treatments for non-small-cell lung cancer.
By
The studies describe new methods for accelerating drug approvals during pandemics and for providing more accurate measures of the probabilities of success for clinical trials of vaccines.
By
MIT Sloan and CSAIL researchers apply artificial intelligence techniques to one of the largest datasets of clinical trial outcomes to handicap the drug and device approval process
By
Despite Vietnam’s transition to an emerging economy, the healthcare sector has not witnessed the same progress seen in other sectors. Vietnam is a country of innovators and entrepreneurs, and this should be leveraged to address the country’s healthcare challenges.
By
The MIT Laboratory for Financial Engineering (LFE) and Informa Pharma Intelligence announced a new initiative, Project ALPHA (Analytics for Life-sciences Professionals and Healthcare Advocates).
Researchers launched an in-house Data Science and Artificial Intelligence (DSAI) challenge to beat MIT’s machine-learning models for predicting clinical trial outcomes. The results are now available.
By
From professional education courses to mobile apps that monitor crop yields, these startups aim to kick-start innovation ecosystems across the globe.
By
In a new book about the history of Kendall Square from the MIT Press, author Robert Buderi chronicles the area's biggest successes in innovation.
